Do digital biomarkers represent an opportunity to capture clinically meaningful, objective data? With the rise of connected sensor technologies, there are seemingly endless possibilities for new ways to measure health. How do we select and develop digital measurements in research and clinical care that are meaningful for patients and physicians? What measures are already in use and where - trials, real world, or both? How do traditional and digital measures interact/integrate in clinical practice? How should they be standardized?